Spotlight on Diabetes
Return to CIRM Meetings and Events
Spotlight on Diabetes
On September 25, 2008, the CIRM Governing Board heard from three speakers about the promise of stem cell research in treating Type 1 diabetes, formerly known as juvenile diabetes. They learned about CIRM-funded stem cell research from Emmanuel Baetge, current treatments for diabetes from Peter Butler, and life with diabetes from Joelle Johnson.
- Welcoming remarks, Robert Klein, JD, chair of the governing board
- Peter Butler, M.D., director of the Larry Hillblom Islet Research Center at the University of California, Los Angeles
- Emmanuel Baetge, Ph.D., vice president and chief scientific officer for Novocell Inc.
- Joelle Johnson, patient with type 1 diabetes
Date Published: June 30, 2010
Last Modified: April 5, 2017
Last Modified: April 5, 2017